A multicenter randomized controlled trial of a liquid loperamide product versus placebo in the treatment of acute diarrhea in children
Abstract
This randomized, double-blind, placebo-controlled trial of 48 hours' duration conducted in 13 primary care ambulatory practices in the United States and Mexico was used to compare the efficacy and safety of loperamide with placebo for the treatment of acute diarrhea in children aged 2 through 11 yea …
Keywords
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
female
male
Child
Infant
preschool
Clinical Trial
Randomized Controlled Trial
Double-Blind Method
Multicenter Study
placebos
acute disease
diarrhea
loperamide / therapeutic use*
pmid:10544864
doi:10.1177/000992289903801003
m a kaplan
m j prior
e b nelson
infantile / drug therapy*
loperamide / pharmacology
Access
Citation
ID:
115278
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
115278
Unique Identifier:
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet